{"id":"NCT01697501","sponsor":"Hoffmann-La Roche","briefTitle":"A Study Evaluating IL28B Polymorphism in Patients With HBeAg-Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML18253","officialTitle":"Cross-sectional Multicenter Study Evaluating the IL28B Polymorphism in Patients With HBeAg-negative Chronic Hepatitis B Treated With Pegylated Interferon Alfa-2a in the Course of Peg.Be.Liver Study","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-11-08","primaryCompletion":"2013-06-21","completion":"2013-06-21","firstPosted":"2012-10-02","resultsPosted":"2015-07-10","lastUpdate":"2017-04-10"},"enrollment":88,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"OTHER"},"conditions":["Hepatitis B, Chronic"],"interventions":[{"type":"OTHER","name":"Interleukin 28B testing","otherNames":[]}],"arms":[{"label":"Chronic hepatitis B patients","type":"EXPERIMENTAL"}],"summary":"This cross-sectional multicenter study will evaluate the IL28B polymorphism in patients with HBeAg-negative chronic hepatitis B treated with Pegasys (peginterferon alfa-2a) in the predecessor ML18253 study. The study consists of a single visit where eligible patients will undergo a blood test for IL28B genotyping, with a phone follow-up 7 days after the visit.","primaryOutcome":{"measure":"Percentage of Participants With Sustained Viral Response (SVR) Defined as HBV DNA â‰¤ 2000 IU/ml at IL28B Genotype rs12979860 at End of Follow-up (EoF)","timeFrame":"EoF, as defined in the predecessor study, was at 48 weeks after the end of treatment.","effectByArm":[{"arm":"\"CC\"","deltaMin":20,"sd":null},{"arm":"\"TC\"","deltaMin":17.1,"sd":null},{"arm":"\"TT\"","deltaMin":20,"sd":null},{"arm":"\"TC+TT\"","deltaMin":17.6,"sd":null},{"arm":"\"Overall\"","deltaMin":18.6,"sd":null}],"pValues":[{"comp":"OG000 vs OG003","p":"0.7831"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":1},"locations":{"siteCount":12,"countries":["Italy"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":88},"commonTop":[]}}